Zolpidem Tartrate

CAS 99294-93-6 21 current records 12 historicalSmall Molecule

Who holds supplier records for Zolpidem Tartrate? 21 organisations hold a current record for Zolpidem Tartrate: an active US FDA Type II Drug Master File or a CEP. A further 12 organisations have only historical (inactive) DMF filings. 14 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (13), Italy (1), France (1) and Netherlands (1); not recorded for 5.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Zolpidem Tartrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/zolpidem-tartrate

Reading the evidence

  • 21 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    13 of the 16 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 15 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (21)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Zolpidem Tartrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India13Italy1France1Netherlands1Country not recorded for 5
Need Zolpidem Tartrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (14)

Certificates of Suitability on the EDQM register for Zolpidem Tartrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 24 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2007-102 - Rev 07
Zolpidem tartrate
Oct 2026—
CZECH-GEN A.S. OlomoucCZ
CEP 2000-319 - Rev 07
Zolpidem tartrate
Jul 2026Inspected Sept 2024
Czechia
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2020-320 - Rev 03
Zolpidem tartrate, Site-II
Oct 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2006-293 - Rev 08
Zolpidem tartrate
Sept 2025—
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2005-067 - Rev 03
Zolpidem tartrate
Aug 2025—
LAKE CHEMICALS PRIVATE LIMITED BengaluruIN
CEP 2018-022 - Rev 02
Zolpidem tartrate
Jul 2025—
CENTAUR PHARMACEUTICALS PRIVATE LIMITED MumbaiIN
CEP 2002-171 - Rev 07
Zolpidem tartrate
Jun 2025—
TAPI NL B.V. AmsterdamNL
CEP 2004-159 - Rev 05
Zolpidem tartrate
Feb 2025—
UNICHEM LABORATORIES LIMITED MumbaiIN
CEP 2008-153 - Rev 01
Zolpidem tartrate
Nov 2024—
SANOFI WINTHROP INDUSTRIE GentillyFR
CEP 2001-071 - Rev 05
Zolpidem tartrate
Mar 2024—
AARTI DRUGS LIMITED MumbaiIN
R1-CEP 2002-082 - Rev 05
Zolpidem tartrate
Jan 2023—
Cambrex Profarmaco Milano S.r.l. PaulloIT
R1-CEP 2005-035 - Rev 04
Zolpidem tartrate
Nov 2020—
LUPIN LIMITED MumbaiIN
R1-CEP 2006-032 - Rev 01
Zolpidem tartrate
Sept 2016—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
R1-CEP 2007-222 - Rev 00
Zolpidem tartrate
Jul 2014—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (12)

Organisations whose Type II DMFs for Zolpidem Tartrate are no longer active. These show a past filing, not current supply.

Show all 12 historical records
  • Netherlands · Inactive DMF 22668 · filed Mar 2009
  • India · Inactive DMF 19224 · filed Mar 2006
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 18982 · filed Nov 2005
  • India · Inactive DMF 18808 · filed Sept 2005
  • SHANDONG LUNAN BETTER PHARMACEUTICAL CO LTD
    Inactive DMF 18697 · filed Aug 2005
  • India · Inactive DMF 17811 · filed Nov 2004
  • Germany · Inactive DMF 16940 · filed Oct 2003
  • Czechia · Inactive DMF 16624 · filed Jun 2003
  • Spain · Inactive DMF 15840 · filed Jan 2002
  • Argentina · Inactive DMF 10652 · filed Jan 1994
  • SYNTHELABO BP
    Inactive DMF 9159 · filed Jun 1991
  • LABORATOIRES DETUDES ET DE RECHERCHES SYNTHELABO
    Inactive DMF 6622 · filed Oct 1986

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Zolpidem Tartrate is a sedative-hypnotic used in the short-term treatment of insomnia. It is an imidazopyridine derivative that enhances GABA receptor activity, facilitating sleep.

Chemical identity

IUPAC name
(2R,3R)-2,3-dihydroxybutanedioic acid;bis(N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide)
Canonical SMILES
CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C.CC1=CC=C(C=C1)C2=C(N3C=C(C=CC3=N2)C)CC(=O)N(C)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
InChIKey
VXRDAMSNTXUHFX-CEAXSRTFSA-N
Synonyms
Ambien API, ambien, intermezzo, ivadal, myslee, niotal, sl 80.0750-23n, sl-80.0750, sl-80.0750-23n, stilnoct, stilnox, tovalt

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
gamma-Aminobutyric Acid A Receptor Positive Modulator; gamma-Aminobutyric Acid-ergic Agonist
Mechanism of action
GABA A Agonists; GABA A Receptor Positive Modulators
Physiologic effect
Central Nervous System Depression
Chemical structure
Pyridines

Therapeutic areas

Insomnia

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Zolpidem Tartrate?

21 organisations hold an active US FDA Type II Drug Master File or a CEP for Zolpidem Tartrate: ALIVUS LIFE SCIENCES LTD (India), AARTI DRUGS LTD (India), APITORIA PHARMA PRIVATE LTD (India), CAMBREX PROFARMACO MILANO SRL (Italy), CENTAUR PHARMACEUTICALS PVT LTD (India), CZECH-GEN AS, Lupin Limited (India) and MATRIX PHARMACORP PRIVATE LTD (India), and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Zolpidem Tartrate Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 18164, 31894), AARTI DRUGS LTD (DMF 19440), APITORIA PHARMA PRIVATE LTD (DMF 18974), CAMBREX PROFARMACO MILANO SRL (DMF 17098), CENTAUR PHARMACEUTICALS PVT LTD (DMF 30781), CZECH-GEN AS (DMF 15486), Lupin Limited (DMF 18430) and MATRIX PHARMACORP PRIVATE LTD (DMF 18221) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Zolpidem Tartrate records mean?

12 organisations have only inactive Type II DMFs for Zolpidem Tartrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Zolpidem Tartrate have a European Certificate of Suitability?

Yes. 14 organisations hold a valid CEP for Zolpidem Tartrate on the EDQM register, including ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), CZECH-GEN A.S. Olomouc (CZ), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN) and LAKE CHEMICALS PRIVATE LIMITED Bengaluru (IN) and 8 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Zolpidem Tartrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Zolpidem Tartrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.